Comparison of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Primary Plasma Cell Leukemia in Japan

This publication has 26 references indexed in Scilit:

• European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
  Annals of Oncology, 2025
• Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study
  Annals of Hematology, 2024
• Current Status on Management of Primary Plasma Cell Leukemia
  Current Oncology Reports, 2024
• Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management
  American Journal of Hematology, 2024
• Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
  International Journal of Hematology, 2023
• Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group
  American Journal of Hematology, 2023
• Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment
  Leukemia Research, 2021
• Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)
  International Journal of Hematology, 2015
• Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
  Transplantation and Cellular Therapy, 2009
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report
  Transplantation and Cellular Therapy, 2005